BiotechTube

Valemetostat tosylate

Phase 2Active
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Lymphoma, B-Cell

Conditions

Lymphoma, B-Cell

Trial Timeline

Jun 11, 2021 → Oct 1, 2026

NCT ID
NCT04842877

About Valemetostat tosylate

Valemetostat tosylate is a phase 2 stage product being developed by Daiichi Sankyo for Lymphoma, B-Cell. The current trial status is active. This product is registered under clinical trial identifier NCT04842877. Target conditions include Lymphoma, B-Cell.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (4)

NCT IDPhaseStatus
NCT07303387Phase 2Recruiting
NCT04842877Phase 2Active
NCT04703192Phase 2Active
NCT04102150Phase 2Completed

Competing Products

20 competing products in Lymphoma, B-Cell

See all competitors
ProductCompanyStageHype Score
AFM13AffimedPhase 2
44
Pirtobrutinib + Brexucabtagene AutoleucelEli LillyPhase 2
52
EnzastaurinEli LillyPhase 2
52
Avastin + Gemcitabine + Oxaliplatin + Pegaspargase + DexamethasoneEli LillyPhase 2
52
Gemcitabine-Oxaliplatin plus Rituximab (R-GEMOX)Eli LillyPhase 2
52
VIP152 + BTKiVincerx PharmaPhase 1
25
Tomivosertib (eFT-508)eFFECTOR TherapeuticsPhase 1/2
33
Nanatinostat in combination with valganciclovirViracta TherapeuticsPhase 2
44
Sepantronium BromideCothera BiosciencePhase 2
44
Copanlisib + RituximabCelltrionPhase 2
52
Rituximab + PembrolizumabCelltrionPhase 2
52
Rituximab + Methotrexate + Cytarabine InjectionCelltrionPhase 2
52
rituximabCelltrionPhase 1
33
CT-P10 + RituxanCelltrionPhase 3
77
Rituxan + CT-P10 + Cyclophosphamide + Vincristine + PrednisoneCelltrionPhase 3
77
Rituximab, lenalidomideCelltrionPhase 2
52
Rituximab + Lenalidomide + ValemetostatDaiichi SankyoPhase 1/2
41
PLX3397Daiichi SankyoPhase 2
52
Valemetostat TosylateDaiichi SankyoPhase 2
52
HMPL-689HUTCHMEDPhase 1
28

Other Products from Daiichi Sankyo

Olmesartan medoxomil + Olmesartan medoxomil/hydrochlorothiazide + HydrochlorothiazideApproved
85
OAC aloneApproved
85
olmesartan medoxomil + Placebo + losartan potassiumApproved
85
Prasugrel + ClopidogrelApproved
85
Diet+pravastatinApproved
85